Nature Nanotechnology paper shows enzyme-controlled movement of DNA polymer through a nanopore
Notes to Editors
Reference: Replication of individual DNA molecules under electronic control using a protein nanopore. Felix Olasagasti, Kate R. Lieberman, Seico Benner, Gerald M. Cherf, Joseph M. Dahl, David W. Deamer and Mark Akeson Nature Nanotechnology September 2010.
DOI: 10.1038/NNANO.2010.177, (subscription needed) http://www.nature.com/nnano/journal/vaop/ncurrent/full/nnano.2010.177.html
Work conducted in this paper
In this Nature Nanotechnology paper, DNA replication was catalyzed by bacteriophage T7 DNA polymerase (T7DNAP) and by the Klenow fragment of DNA polymerase I (KF) in order to drive ssDNA through the nanopore. The T7DNAP enzyme advanced on a DNA template against an 80 mV load applied across the nanopore, and single nucleotide additions were measured on the millisecond time scale for hundreds of individual DNA molecules in series. When using the KF enzyme, nucleotide additions were not observed when the enzyme was directly on the pore, but using electronic feedback, KF enzymes were allowed to act on the strand while in the solution above the pore, resulting in a controlled movement of the strand.
Base identification during strand sequencing
In addition to achieving fine control of DNA translocation through a nanopore, a key challenge for strand sequencing is accurate identification of individual nucleotides on ssDNA. When passing through AHL,10-15 bases on a ssDNA polymer will span the pore's central channel. Strategies are in development for distinguishing single bases, for example researchers at the University of Oxford have previously published a method to correctly identify individual nucleotides on ssDNA immobilised within an AHL nanopore. Further work continues at Oxford Nanopore and in the laboratories of the Company's collaborators.
Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies Ltd is developing a revolutionary technology for direct, electrical detection and analysis of single molecules. The platform is designed to offer substantial benefits in a variety of applications. The Company's lead application is DNA sequencing, but the platform is also adaptable for protein analysis for diagnostics and drug development and identification of a range of other molecules for security & defence and environmental monitoring. The technology is modular and highly scalable, driven by electronics rather than optics.
The Company's first generations of DNA sequencing technology, Exonuclease sequencing and Strand sequencing, combine a protein nanopore with a processive enzyme, multiplexed on a silicon chip. This elegant and scalable system has unique potential to transform the speed and cost of DNA sequencing. Oxford Nanopore also has collaborative projects in the development of solid state nanopores for further improvements in speed and cost. For further information please visit www.nanoporetech.com.